UNSPSC 51263705: Tilisolol hydrochloride

This classification denotes a beta-adrenergic blocking agent C17H24N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JW02T8UTIN, chemically known as tilisolol hydrochloride, (+/-)-, but more generally known as tilisolol hydrochloride, which bears US NIH Compound Identifier 44155. European Medicines Agency schedules Tilisolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04871MIG.

Most nations, for tariff and trade purposes, schedule tilisolol hydrochloride under HS 29337900 and SITC 51561. As of Q4 2014, TILISOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)(C)NCC(COC1CN(C(=O)C2C1CCCC2)C)O.CL.

UNSPSC 51263705 Tilisolol hydrochloride is a Commodity code that in recent state and local procurement activity aligns with pharmaceutical and medical supply procurement, though the single available opportunity shows a mismatch between the code's nominal scope and what is actually being solicited. Seminole County, Florida recently posted an IFB for Naloxone and drug deactivation systems — products unrelated to tilisolol hydrochloride, a beta-blocker pharmaceutical — suggesting either a coding error in the county's tagging or limited recent activity under this Commodity code that reflects genuine demand. The opportunity indicates that state and local health agencies do use competitive bidding to source pharmaceuticals and related medical supplies, typically with multi-year terms, quarterly or regular delivery cycles, and standard insurance and compliance requirements including E-Verify and drug-free workplace certification.

The geographic and recent-activity data are limited to a single posting. Seminole County's IFB (IFB60459723LAS), posted June 30, 2026 with a response deadline of July 26, 2023, represents the only recent opportunity available under this code. Given the single posting and the product mismatch, this Commodity code shows minimal relevant recent activity in state and local procurement. Business development professionals should verify whether tilisolol hydrochloride demand exists in their target jurisdictions through direct outreach to county health departments, public health agencies, and municipal procurement offices rather than relying on coded opportunity flow under this category.